A study in healthy people to test how empagliflozin is taken up in the body when taken as a whole tablet or dissolved in water and mixed with food
This study is for healthy volunteers and aims to understand how a specific medication, empagliflozin, is absorbed by the body. Researchers want to compare two ways of taking the medicine: as a whole tablet or after dissolving it in water and mixing it with food. The main goal is to see if the way it's taken affects how much of the medicine gets into your system and how quickly. This is an early stage study, meaning it's one of the first times this kind of detailed testing is being done in people to learn about the drug's properties.
At a glance
What is this study about?
Imagine you take a vitamin tablet. Your body needs to break it down and absorb it for it to work. This study is exploring something similar with a medicine called empagliflozin. We want to understand exactly how this medicine gets into the body and if changing the way it's taken makes a difference. Specifically, we'll look at whether swallowing a tablet whole is different from dissolving it in water and then mixing it with some food before you eat it. This helps scientists learn more about the medicine itself.
Studies like this are really important because they help doctors and pharmacists understand the best way for people to take their medicines. Even small differences in how a medicine is absorbed can affect how well it works or if there are any side effects. By carefully studying this, we can make sure that in the future, if this medicine is used more widely, patients are given the clearest and most effective instructions on how to use it.
This is an early stage study, which means it’s one of the first detailed investigations into how this particular medicine behaves in humans. It's not about treating a specific illness, but rather about gathering fundamental information about the medicine. Healthy volunteers are crucial for these types of studies because they allow researchers to observe the drug's effects without other health conditions complicating the results.
Key takeaways
- This study helps scientists understand how a medicine gets into the body.
- It compares taking a tablet whole versus dissolved in water with food.
- It's for healthy adults, aged 18 and over, both men and women.
- Participation involves clinic visits, taking the medicine, and blood tests.
- The study aims to improve future medicine instructions for patients.
- You can withdraw from the study at any time.
Who may be eligible?
This study is looking for healthy adults. You need to be at least 18 years old. There's no upper age limit, meaning older adults can also take part if they are healthy.
Both men and women are welcome to participate in this study. The main requirement is that you are generally well and don't have any serious ongoing health conditions that might affect how your body handles the medicine being studied.
Before you can join, a doctor involved in the study will check your health to make sure it's safe for you to take part. This usually involves some simple tests and questions about your medical history.
- Are you 18 years old or older?
- Do you consider yourself generally healthy?
- Are you able to attend study clinic appointments?
- Are you comfortable with giving blood samples?
- Are you able to follow specific instructions for taking medication?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part, you'll be asked to visit the study clinic several times. During these visits, you'll receive the empagliflozin medicine, either as a tablet or dissolved in water and mixed with food, depending on which group you're in. We'll then take blood samples at different times to see how the medicine is moving through your body. You might also have other checks, like your blood pressure or a heart tracing (ECG).
There won't be a long period of taking medication at home; the study will focus on specific observation periods after you take the medicine. You'll be closely monitored by medical staff throughout your time at the clinic. The total time you'll be involved in the study, including all visits and follow-up, will be explained to you fully before you decide to join.
Potential risks and benefits
Locations (1)
- —Germany
Common questions
What is empagliflozin?
Empagliflozin is a medicine that helps the body process sugar. In this study, we are not using it to treat an illness, but to understand how it behaves in healthy people.
Why do you need healthy people for this study?
Using healthy volunteers helps us see how the medicine works in a 'normal' body without other health conditions affecting the results. This gives us clear information about the drug itself.
Will I get paid for taking part?
Many clinical trials offer some payment for your time and travel. This will be explained in detail if you are interested in joining.
How long will the study visits take?
The length of each visit will vary, but some might be several hours long, especially when we need to take multiple blood samples. The full schedule will be provided.
What happens if I change my mind after joining?
You are free to leave the study at any time, for any reason, even after you've started. This will not affect any medical care you usually receive.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.